EBV can increase the expression of SLC7A11 and GPX4 by activating the p62-Keap1-NRF2 signaling pathway, making nasopharyngeal cancer cells more resistant to ferroptosis. The gene discussed is GPX4; the disease is nasopharyngeal carcinoma.